Literature DB >> 20145031

Late-onset Huntington disease with intermediate CAG repeats: true or false?

Justus L Groen1, Rob M A de Bie, Elisabeth M J Foncke, Raymund A C Roos, Klaus L Leenders, Marina A J Tijssen.   

Abstract

Huntington disease (HD) is a neurodegenerative disorder associated with an expanded CAG trinucleotide repeat length in the huntingtin gene. 'Intermediate alleles' with 27 to 35 CAG repeats generally do not cause HD but are unstable upon germ-line transmission. Insights in CAG repeat mosaicism and enhanced trinucleotide expansion in postmitotic neurons indicate that in the intermediate range, other factors than the CAG repeat length in diagnostic tests have to be considered. Here, we report two patients with mild, late onset HD and an intermediate repeat allele. The authors anticipate that intermediate repeats can cause late-onset HD due to disease modifiers and may be more common than previously stated.

Entities:  

Mesh:

Year:  2010        PMID: 20145031     DOI: 10.1136/jnnp.2008.170902

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  17 in total

1.  Increased irritability, anxiety, and immune reactivity in transgenic Huntington's disease monkeys.

Authors:  Jessica Raper; Steven Bosinger; Zachary Johnson; Gregory Tharp; Sean P Moran; Anthony W S Chan
Journal:  Brain Behav Immun       Date:  2016-07-07       Impact factor: 7.217

2.  Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS.

Authors:  Annie Killoran; Kevin M Biglan; Joseph Jankovic; Shirley Eberly; Elise Kayson; David Oakes; Anne B Young; Ira Shoulson
Journal:  Neurology       Date:  2013-04-26       Impact factor: 9.910

3.  FMR1 gray-zone alleles: association with Parkinson's disease in women?

Authors:  Deborah A Hall; Elizabeth Berry-Kravis; Wenting Zhang; Flora Tassone; Elaine Spector; Gary Zerbe; Paul J Hagerman; Bichun Ouyang; Maureen A Leehey
Journal:  Mov Disord       Date:  2011-05-12       Impact factor: 10.338

4.  Phenotype Characterization of HD Intermediate Alleles in PREDICT-HD.

Authors:  Nancy R Downing; Spencer Lourens; Isabella De Soriano; Jeffrey D Long; Jane S Paulsen
Journal:  J Huntingtons Dis       Date:  2016-12-15

5.  Molecular interaction between the chaperone Hsc70 and the N-terminal flank of huntingtin exon 1 modulates aggregation.

Authors:  Elodie Monsellier; Virginie Redeker; Gemma Ruiz-Arlandis; Luc Bousset; Ronald Melki
Journal:  J Biol Chem       Date:  2014-12-10       Impact factor: 5.157

6.  "Grasping the grey": patient understanding and interpretation of an intermediate allele predictive test result for Huntington disease.

Authors:  A Semaka; L G Balneaves; M R Hayden
Journal:  J Genet Couns       Date:  2012-08-18       Impact factor: 2.537

Review 7.  Huntington's Disease: Relationship Between Phenotype and Genotype.

Authors:  Yi-Min Sun; Yan-Bin Zhang; Zhi-Ying Wu
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

8.  Late-onset Huntington's disease associated with CAG repeat lengths of 30 and 31.

Authors:  Thomas B Stoker; Simon T Holden; Roger A Barker
Journal:  J Neurol       Date:  2021-06-17       Impact factor: 4.849

9.  Intermediate CAG Repeats in Huntington's Disease: Analysis of COHORT.

Authors:  Ainhi D Ha; Christopher A Beck; Joseph Jankovic
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-02-02

10.  EMQN/CMGS best practice guidelines for the molecular genetic testing of Huntington disease.

Authors:  Monique Losekoot; Martine J van Belzen; Sara Seneca; Peter Bauer; Susan A R Stenhouse; David E Barton
Journal:  Eur J Hum Genet       Date:  2012-09-19       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.